Citation Impact
Citing Papers
A unique type of GSK-3 inhibitor brings new opportunities to the clinic
2016
Sleep Drives Metabolite Clearance from the Adult Brain
2013 StandoutScience
Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-β Precursor Protein
2012
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Roles of tau protein in health and disease
2017
The dynamics of monocytes and microglia in Alzheimer’s disease
2015
Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
2010
Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences
2011
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
2010
The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells
2008
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
2009
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia
2009
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
2017
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
The link between altered cholesterol metabolism and Alzheimer's disease
2012
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis
2009
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
2019
The role of autophagy in neurodegenerative disease
2013 Standout
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model
2012
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Involvement of ROS in BBB dysfunction
2009
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease
2008
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
2008
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
An Association of Virus Infection with Type 2 Diabetes and Alzheimer’s Disease
2014
Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid–Alzheimer's disease relationships?
2010
Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain
2010
Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death
2014
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Diabetic Retinopathy
2012 Standout
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
2012
Establishment and Dysfunction of the Blood-Brain Barrier
2015
A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
2012
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
2008
Blood protein predictors of brain amyloid for enrichment in clinical trials?
2015 StandoutNobel
Simultaneous nitric oxide and dehydroascorbic acid imaging by combining diaminofluoresceins and diaminorhodamines
2007
Wilson's disease and other neurological copper disorders
2014
Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
2013 Standout
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
2009
Antibody Therapeutics Targeting Aβ and Tau
2017
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
2007
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Alzheimer's disease: clinical trials and drug development
2010
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Aβ accumulation in AD brain
2010
SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease
2008
Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer’s Disease?
2016
Circulating neprilysin clears brain amyloid
2010
The Pathobiology of Vascular Dementia
2013 Standout
The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier Aβ Clearance in Alzheimers Disease
2008
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
2008 Standout
In vivo expression of aquaporin‐4 by reactive microglia
2004
Expression of Neprilysin in Skeletal Muscle Reduces Amyloid Burden in a Transgenic Mouse Model of Alzheimer Disease
2009
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
2008
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin
2011 StandoutNobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
2009 StandoutNobel
Biological metals and metal-targeting compounds in major neurodegenerative diseases
2014
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Predicting Alzheimer disease from a blood-based biomarker profile
2016 StandoutNobel
Microvascular protection is essential for successful neuroprotection in stroke
2012
The Expression of Contextual Fear Conditioning Involves Activation of an NMDA Receptor-Nitric Oxide Pathway in the Medial Prefrontal Cortex
2007
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
2016
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
2012
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Reversible Near-Infrared Fluorescent Probe Introducing Tellurium to Mimetic Glutathione Peroxidase for Monitoring the Redox Cycles between Peroxynitrite and Glutathione in Vivo
2013 Standout
Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα
2018
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
2013
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
2015 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease
2011
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
2018
A Near-IR Reversible Fluorescent Probe Modulated by Selenium for Monitoring Peroxynitrite and Imaging in Living Cells
2011 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
A Phase II Trial of Tideglusib in Alzheimer's Disease
2015
Performance Characteristics of Plasma Amyloid-β 40 and 42 Assays
2009
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Erythropoietin: Powerful protection of ischemic and post-ischemic brain
2014
Physiology of Microglia
2011 Standout
Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
2012
Works of Mireia Coma being referenced
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence
2018
The physiology and pathophysiology of nitric oxide in the brain
2005
Clearance of amyloid-β by circulating lipoprotein receptors
2007
Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease
2011
Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination
2005
Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation
2009
A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
2009
Differential Voltage-dependent K+ Channel Responses during Proliferation and Activation in Macrophages
2003
Mild cholesterol depletion reduces amyloid‐β production by impairing APP trafficking to the cell surface
2009
Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet
2010
Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance
2013